National Center for Complementary & Alternative Medicine; Notice of Closed Meetings, 56993 [06-8328]

Download as PDF Federal Register / Vol. 71, No. 188 / Thursday, September 28, 2006 / Notices ESO–1/CAG–3-specific T cells to elicit an anti-cancer immunogenic response and thereby eliminating or reducing the cancer. While these vaccines and pharmaceutical compositions may be developed for use against a variety of cancers, data obtained to date indicate that they may be of particular value for use against melanoma. Methods for diagnosing cancer via the detection of NY ESO–1/CAG–3 are also embodied in the invention. Inventors: Steven A. Rosenberg (NCI) et al. Patent Status: U.S. Patent No. 7,084,239 issued 01 Aug 2006 (HHS Reference No. E–265–1997/0–US–04). Licensing Status: Available for nonexclusive licensing or exclusive licensing. Licensing Contact: Jesse S. Kindra, J.D.; 301/435–5559; kindraj@mail.nih.gov. Dated: September 20, 2006. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E6–15975 Filed 9–27–06; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Clinical Center; Amended Notice of Meeting sroberts on PROD1PC70 with NOTICES Notice is hereby given of a change in the meeting of the NIH Advisory Board for Clinical Research, September 29, 2006, 10 a.m. to September 29, 2006, 2 p.m. National Institutes of Health, Building 10, 10 Center Drive, 4–2551, CRC Medical Board Room, Bethesda, MD 20892 which was published in the Federal Register on September 8, 2006, FR 06–7534. The open session will occur from 10 a.m.–1:30 p.m. The closed session will begin approximately at 1:30 p.m. and run until 2 p.m. The meeting will be held in the Clinical Center, Bldg. 10, Rm. 4–2551, CRC Medical Board Room. The meeting is partially Closed to the public. Dated: September 19, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–8329 Filed 9–27–06; 8:45 am] BILLING CODE 4140–01–M VerDate Aug<31>2005 20:16 Sep 27, 2006 Jkt 208001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant application, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Basic Science. Date: October 23–24, 2006. Time: 8 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Dale L. Birkle, PhD, Scientific Review Administrator, Office of Scientific Review, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 451–6570, birkled@mail.nih.gov. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Clinical Research. Date: October 30–31, 2006. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Jeanette M. Hosseini, PhD, Scientific Review Administrator, Office of Scientific Review, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 594–9096, jeanetteh@mail.nih.gov. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Clinical Research Huntington’s Disease. Date: October 31, 2006. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Jeanette M. Hosseini, PhD, Scientific Review Administrator, Office of PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 56993 Scientific Review, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 594–9096, jeanetteh@mail.nih.gov. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Developmental Centers for Research on CAM. Date: November 16–17, 2006. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda, Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Martina Schmidt, PhD, Scientific Review Administrator, Office of Scientific Review, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 594–3456, schmidma@mail.nih.gov. Dated: September 19, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–8328 Filed 9–27–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which wouldconstitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Tropical Medicine Research Centers. Date: October 16–18, 2006. Time: 8 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Gary S. Madonna, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/ E:\FR\FM\28SEN1.SGM 28SEN1

Agencies

[Federal Register Volume 71, Number 188 (Thursday, September 28, 2006)]
[Notices]
[Page 56993]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8328]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Alternative Medicine; Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant application, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Complementary and 
Alternative Medicine Special Emphasis Panel; Basic Science.
    Date: October 23-24, 2006.
    Time: 8 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Dale L. Birkle, PhD, Scientific Review 
Administrator, Office of Scientific Review, National Center for 
Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd., 
Suite 401, Bethesda, MD 20892, (301) 451-6570, birkled@mail.nih.gov.

    Name of Committee: National Center for Complementary and 
Alternative Medicine Special Emphasis Panel; Clinical Research.
    Date: October 30-31, 2006.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road, NW., Washington, DC 20015.
    Contact Person: Jeanette M. Hosseini, PhD, Scientific Review 
Administrator, Office of Scientific Review, National Center for 
Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd., 
Suite 401, Bethesda, MD 20892, (301) 594-9096, 
jeanetteh@mail.nih.gov.

    Name of Committee: National Center for Complementary and 
Alternative Medicine Special Emphasis Panel; Clinical Research 
Huntington's Disease.
    Date: October 31, 2006.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road, NW., Washington, DC 20015.
    Contact Person: Jeanette M. Hosseini, PhD, Scientific Review 
Administrator, Office of Scientific Review, National Center for 
Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd., 
Suite 401, Bethesda, MD 20892, (301) 594-9096, 
jeanetteh@mail.nih.gov.

    Name of Committee: National Center for Complementary and 
Alternative Medicine Special Emphasis Panel; Developmental Centers 
for Research on CAM.
    Date: November 16-17, 2006.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda, Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Martina Schmidt, PhD, Scientific Review 
Administrator, Office of Scientific Review, National Center for 
Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd., 
Suite 401, Bethesda, MD 20892, (301) 594-3456, 
schmidma@mail.nih.gov.


    Dated: September 19, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-8328 Filed 9-27-06; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.